TIMP1 and cancer: One possible explanation is that TIMP-1 released by cancer cells during the prior 48-h cisplatin treatment more effectively blocks migration if HUVECs are immediately exposed to the total TIMP-1 content of CM prior to being subjected to the upper chamber.